Moxifloxacin: overview and clinical applications

Moxifloxacin is a broad-spectrum fluoroquinolone antibiotic mainly used to treat bacterial infections, such as community-acquired pneumonia, acute exacerbations of chronic bronchitis, sinusitis and skin infections. It is characterized by broad antibacterial spectrum, high bioavailability and low drug resistance. The content will focus on its pharmacological effects, indications, medication precautions and manufacturers, focusing on its clinical application value and safety.

Pharmacological effects and antibacterial spectrum

Moxifloxacin blocks DNA replication by inhibiting bacterial DNA gyrase and topoisomerase IV, and is highly effective against Gram-positive bacteria, negative bacteria and atypical pathogens (such as mycoplasma and chlamydia). Compared with other quinolones, it is more active against Streptococcus pneumoniae and anaerobic bacteria, and has a lower resistance rate. Clinical studies have shown that its oral absorption rate exceeds 90%, food has little impact on it, and is suitable for outpatient treatment.

Indications, usage and dosage

Moxifloxacin is suitable for adults with respiratory, skin and soft tissue infections. The usual dose is 400mg once a day, and the course of treatment is adjusted according to the type of infection (such as pneumonia, 5-10 days). Care should be taken to avoid taking it with metal ion drugs to avoid reducing the efficacy. Special groups (such as those with renal insufficiency) do not need to adjust the dose, but it is contraindicated in pregnancy, lactation and patients under 18 years old.

Adverse reactions and precautions

Common adverse reactions include gastrointestinal reactions (nausea, diarrhea), dizziness and photosensitivity reactions. Rare but serious adverse reactions include QT interval prolongation, tendonitis, etc. During medication, avoid direct sunlight and monitor electrocardiogram (especially in patients with heart disease). Long-term use may induce drug-resistant bacteria, so medical advice must be strictly followed.

Summary and production information

Moxifloxacin is an efficient and convenient antibacterial drug, but the risks and benefits need to be weighed. Major domestic manufacturers include Bayer (trade name: Bayforex), Jiangsu Hengrui Pharmaceuticals, etc. The following table lists some product information:

Quote sources:
1. "Guidelines for the Clinical Application of Antimicrobial Agents" (2020 Edition)
2. Instructions for Bayer Pharmaceuticals Moxifloxacin
3. National Medical Products Administration drug database